Cytotoxic molecule-positive classical Hodgkin’s lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type

Background Classical Hodgkin’s lymphoma is characterized by Hodgkin and Reed Sternberg cells, which are of B-cell origin in many cases. We recently highlighted the adverse prognostic significance of cytotoxic molecule expression in patients with classical Hodgkin’s lymphoma. However, the clinical characteristics of cytotoxic molecule-positive classical Hodgkin’s lymphoma remain controversial. Design and Methods We investigated the clinicopathological profiles of 32 patients with cytotoxic molecule-positive Hodgkin’s lymphoma, comprising 23 with nodular sclerosis and 9 with mixed cellularity, and compared these profiles with those of 55 patients with cytotoxic molecule-positive nodal peripheral T-cell lymphoma, not otherwise specified and 439 patients with cytotoxic molecule-negative Hodgkin’s lymphoma. Results The patients with cytotoxic molecule-positive Hodgkin’s lymphoma consisted of 20 men and 12 women with a median age of 50 years (range, 19 to 81). All these patients had lymphadenopathy at presentation, and 14 showed mediastinal involvement. Physical findings included hepatomegaly and splenomegaly in six patients each. Four patients had a bulky mass, and nine showed stage IV disease. The tumor cells of patients with cytotoxic molecule-positive Hodgkin’s lymphoma had a prototypic immunophenotype of CD15+ CD30+ CD45RO− fascin+, with positivity for Epstein-Barr virus in 39% of cases. All patients were negative for Pax5. In comparison with patients with cytotoxic molecule-positive nodal peripheral T-cell lymphomas, not otherwise specified, patients with cytotoxic-positive Hodgkin’s lymphoma had relatively mild clinical symptoms, similar to those of patients with cytotoxic molecule-negative Hodgkin’s lymphoma. Regarding prognosis, the survival of patients with cytotoxic molecule-positive Hodgkin’s lymphoma was worse than that of patients with cytotoxic molecule-negative Hodgkin’s lymphoma (P=0.0003) but better than that of patients with cytotoxic molecule-positive peripheral T-cell lymphomas, not otherwise specified (P=0.002). Conclusions Cytotoxic molecule-positive Hodgkin’s lymphoma is characterized by an unfavorable prognosis, even if its clinicopathological features are within the boundaries of classical Hodgkin’s lymphoma. More effective chemotherapy for cytotoxic molecule-positive Hodgkin’s lymphoma is clearly required.

[1]  T. Saida,et al.  A case of systemic anaplastic large cell lymphoma with ‘Hodgkin‐like’ appearance and skin involvement mimicking lymphomatoid papulosis , 2011, Journal of cutaneous pathology.

[2]  T. Papadopoulos,et al.  Rare expression of BSAP (PAX-5) in mature T-cell lymphomas , 2007, Modern Pathology.

[3]  K. Matsuo,et al.  Cytotoxic molecule expression is predictive of prognosis in Hodgkin's‐like anaplastic large cell lymphoma , 2007, Histopathology.

[4]  K. Matsuo,et al.  Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Y. Kagami,et al.  Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified , 2005, The American journal of surgical pathology.

[6]  E. Jaffe,et al.  Peripheral T-Cell Lymphomas Expressing CD30 and CD15 , 2003, The American journal of surgical pathology.

[7]  S. Pileri,et al.  Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases , 2003, Modern Pathology.

[8]  K. Karube,et al.  Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: Classical Hodgkin lymphoma vs. Hodgkin‐like ATLL , 2003, International journal of cancer.

[9]  Clive R. Taylor,et al.  Apoptosis and Cell Cycle-related Genes and Proteins in Classical Hodgkin Lymphoma: Application of Tissue Microarray Technique , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[10]  H. Muller-Hermelink,et al.  The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. , 2003, Blood.

[11]  C. D. Wu,et al.  CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis. , 2003, International journal of oncology.

[12]  J. Delabie,et al.  The Value of Anti-Pax-5 Immunostaining in Routinely Fixed and Paraffin-Embedded Sections: A Novel Pan Pre-B and B-Cell Marker , 2002, The American journal of surgical pathology.

[13]  C. Taylor,et al.  Molecular morphology of Hodgkin lymphoma. , 2001, Applied immunohistochemistry & molecular morphology : AIMM.

[14]  C. Taylor,et al.  Evolving concepts of the nature of Hodgkin's disease: a history. , 2000, Annals of diagnostic pathology.

[15]  H. Stein,et al.  Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. , 2000, Blood.

[16]  K. Rajewsky,et al.  Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma , 2000, The Journal of experimental medicine.

[17]  L. Staudt,et al.  Reed-Sternberg cell genome expression supports a B-cell lineage. , 1999, Blood.

[18]  Y. Yamashita,et al.  Perforin and granzyme expression in cytotoxic T-cell lymphomas. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  K. E. Salhany,et al.  TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. , 1997, The American journal of pathology.

[20]  E. Jaffe,et al.  Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. , 1997, Blood.

[21]  H. Stein,et al.  Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. , 1996, Blood.

[22]  P. Lichter,et al.  The human Met-ase gene (GZMM): structure, sequence, and close physical linkage to the serine protease gene cluster on 19p13.3. , 1994, Genomics.

[23]  P. Heerde,et al.  Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. , 1994, Blood.

[24]  R Fischer,et al.  Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[26]  Y. Shinkai,et al.  Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations. , 1992, International immunology.

[27]  Paul Anderson,et al.  A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells , 1991, Cell.

[28]  J. Tschopp,et al.  Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli. , 1988, Immunology.

[29]  D. Shibata,et al.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction , 1988, The Journal of experimental medicine.

[30]  J. Tschopp,et al.  Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. , 1985, The Journal of biological chemistry.

[31]  V. Diehl,et al.  Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells. , 2004, The Lancet. Oncology.

[32]  L. Medeiros,et al.  Automated high-resolution polymerase chain reaction fragment analysis: a method for detecting T-cell receptor gamma-chain gene rearrangements in lymphoproliferative diseases. , 1998, The American journal of pathology.

[33]  C. Meijer,et al.  Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. , 1996, The American journal of pathology.

[34]  C. Grossi,et al.  Ultrastructural characteristics of human T cell clones with various cytolytic activities , 1983, European journal of immunology.